VANGUARD GROUP INC - 31 Dec 2025 SCHEDULE 13G Report for Amylyx Pharmaceuticals Inc Common Stock (AMLX)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Amylyx Pharmaceuticals Inc Common Stock
Symbol: AMLX
Shares outstanding: 109,941,515 shares
Disclosed Ownership: 5,804,912 shares
Ownership: 5.3%
Form type: SCHEDULE 13G
Filing time: 30 Jan 2026, 13:27:54 UTC
Date of event: 31 Dec 2025
Previous filing: 30 Oct 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	5.3%	5,804,912	0	698,623	Ashley Grim	Head of Global Fund Administration